Pharma To Challenge Legality Of ‘Unfair’ EU Wastewater Directive

The estimated costs to the pharmaceutical and cosmetics industry of introducing a fourth level of urban wastewater treatment are unclear, with the European Commission’s estimate of €1.2bn in dispute.

Pharma argues that more industries should be responsible for covering the cost of additional wastewater treatment. (Shutterstock)

More from Europe

More from Compliance